Dr Reddy’s And Hikma Win Big On US Vascepa Patents

Hikma Considering At-Risk Launch If Originator Appeals

 
• By Dean Rudge
Gavel
The district court's decision could be fruitful for Dr Reddy's and Hikma • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin